You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

severe nonproliferative

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Nonproliferative Diabetic Retinopathy Trial (EYP-1901, Sham IVT)

Not yet recruiting
  • Nonproliferative Diabetic Retinopathy
  • (no location specified)
Aug 3, 2022

Diabetic Retinopathy Trial in Beijing (RC28-E injection)

Recruiting
  • Diabetic Retinopathy
  • RC28-E injection
  • Beijing, Beijing, China
    Beijing Hospital
Jun 10, 2021

Non-proliferative Diabetic Retinopathy Trial (Intravitreal Bevacizumab IVB, Follow-up with regular examination for determination

Unknown status
  • Non-proliferative Diabetic Retinopathy
  • Intravitreal Bevacizumab IVB
  • Follow-up with regular examination for determination of DR progression
  • (no location specified)
Aug 12, 2020

Nonproliferative Diabetic Retinopathy Trial in Worldwide (Intravitreal aflibercept injection [IAI], Sham)

Completed
Has Results
  • Nonproliferative Diabetic Retinopathy
  • Intravitreal aflibercept injection [IAI]
  • Sham
  • Phoenix, Arizona
  • +88 more
Jul 15, 2020

Biochemical Indexes and Retinal Hemodynamic in Different Degrees

Recruiting
  • Diabetic Retinopathy
  • imaging
  • Shenzhen, Guangdong, China
    The Seventh Affiliated Hospital, Sun Yat-sen University
Jun 13, 2023

Diabetic Retinopathy, Diabetic Macular Edema, Diabetic Maculopathy Trial (Screening of DR and DME with artificial intelligence

Not yet recruiting
  • Diabetic Retinopathy
  • +2 more
  • Screening of DR and DME with artificial intelligence using NeoRetina
  • +2 more
  • (no location specified)
Jul 4, 2022

Severe Nonproliferative Diabetic Retinopathy, Diabetic Retinopathy, Diabete Mellitus Trial in Shanghai (Conbercept, Panretinal

Unknown status
  • Severe Nonproliferative Diabetic Retinopathy
  • +2 more
  • Shanghai, Shanghai, China
    Ruijin Hospital
Mar 3, 2019

Diabetic Retinopathy Trial in Créteil (Nutrof, Meralut)

Recruiting
  • Diabetic Retinopathy
  • Nutrof
  • Meralut
  • Créteil, Creteil, France
    CHI Creteil
Dec 14, 2022

Non-proliferative Diabetic Retinopathy Trial (OTX-TKI, Sham)

Not yet recruiting
  • Non-proliferative Diabetic Retinopathy
  • (no location specified)
Jan 12, 2023

Diabetic Retinopathy Trial in Hershey (doxycycline monohydrate, )

Completed
Has Results
  • Diabetic Retinopathy
  • doxycycline monohydrate
  • placebo
  • Hershey, Pennsylvania
    Penn State College of Medicine, Penn State Milton S. Hershey Med
Oct 30, 2018

Eyes With Diabetic Retinopathy

Recruiting
  • Diabetic Retinopathy
    • Daegu, Kyungsangpookdo, Korea, Republic of
      Dong Ho Park
    Feb 17, 2021

    Diabetic Retinopathy Trial in Nashville (Ketorolac 0.45% ophthalmic solution, Placebo - Preservative-free artificial tears,

    Recruiting
    • Diabetic Retinopathy
    • Ketorolac 0.45% ophthalmic solution
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Feb 16, 2022

    Thermal Screening for Early Diabetic Peripheral Neuropathy (DPN)

    Completed
    • Diabetic Neuropathies
    • +2 more
    • no intervention
    • Albuquerque, New Mexico
      VisionQuest Biomedical LLC
    Oct 7, 2020

    Leukemia, Leukemia, Myeloid, Monocytic Leukemia Trial in Palo Alto (Enasidenib mesylat dose escalation)

    Recruiting
    • Leukemia
    • +2 more
    • Enasidenib mesylat dose escalation
    • Palo Alto, California
      Stanford Cancer Institute
    May 12, 2022

    Cystoid Macular Edema Following Cataract Surgery Trial in Zagreb (Bromfenac Ophthalmic 0.09% Ophthalmic Solution, Dexamethasone

    Completed
    • Cystoid Macular Edema Following Cataract Surgery
    • Bromfenac Ophthalmic 0.09% Ophthalmic Solution
    • +3 more
    • Zagreb, Grad Zagreb, Croatia
      KBCZagreb
    May 15, 2022

    Diabetic Retinopathy Trial in Puerto Rico, United States (Aflibercept Injection)

    Recruiting
    • Diabetic Retinopathy
    • Aflibercept Injection
    • Beverly Hills, California
    • +13 more
    Jan 6, 2022

    Mitral Valve Insufficiency Trial (DragonFly Transcatheter Mitral Valve Repair System)

    Not yet recruiting
    • Mitral Valve Insufficiency
    • DragonFly Transcatheter Mitral Valve Repair System
    • (no location specified)
    Jun 30, 2023

    Severe Asthma Trial in Germany

    Recruiting
    • Severe Asthma
      • Altdorf, Germany
      • +44 more
      Sep 12, 2023

      Clinical Characteristics of Severe Childhood Asthma

      Completed
      • Severe Asthma
        • Shanghai, Shanghai, China
          Children's Hospital of Fudan University
        Aug 30, 2023

        Severe Hemophilia A Trial in China (FRSW117)

        Not yet recruiting
        • Severe Hemophilia A
        • Beijing, China
        • +27 more
        Nov 16, 2023

        Microbiome and Host Susceptibility in Severe

        Recruiting
        • Severe Pneumonia
        • metagenomics
        • Hangzhou, Zhejiang, China
        • +13 more
        Nov 2, 2023

        Aortic Stenosis and Mitral Regurgitation by VIS Index and

        Recruiting
        • Severe Aortic Valve Stenosis
        • Severe Mitral Valve Regurgitation
        • Cardiac valve replacement surgery under high spinal anesthesia combined with light general anesthesia
        • Winnipeg, Manitoba, Canada
          Department of Anesthesiology, Perioperative and Pain Medicine, S
        Nov 27, 2023

        COPD Trial in Worldwide (Itepekimab SAR440340, Placebo)

        Recruiting
        • Chronic Obstructive Pulmonary Disease
        • Itepekimab SAR440340
        • Placebo
        • Palm Springs, California
        • +231 more
        Dec 19, 2022

        Hemophilia B Trial (CSL222 (AAV5-hFIXco-Padua))

        Not yet recruiting
        • Hemophilia B
        • CSL222 (AAV5-hFIXco-Padua)
        • (no location specified)
        Aug 14, 2023

        Genital Psoriasis, Scalp Psoriasis Trial (Risankizumab, Placebo for Risankizumab)

        Not yet recruiting
        • Genital Psoriasis
        • Scalp Psoriasis
        • (no location specified)
        Jul 24, 2023